Effects of a gemcitabine plus platinum regimen combined with a dendritic cell-cytokine induced killer immunotherapy on recurrence and survival rate of non-small cell lung cancer patients

The aim of the present study was to investigate the effects of a gemcitabine plus platinum (GP) regimen combined with dendritic cell-cytokine induced killer (DC-CIK) immunotherapy on the recurrence and survival rate in patients with non-small cell lung cancer (NSCLC). Patients (n=157) with stage III...

Descripción completa

Detalles Bibliográficos
Autores principales: ZHAO, MIN, LI, HONGBING, LI, LEI, ZHANG, YIJIE
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2014
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3991503/
https://www.ncbi.nlm.nih.gov/pubmed/24940447
http://dx.doi.org/10.3892/etm.2014.1574

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3991503/
https://www.ncbi.nlm.nih.gov/pubmed/24940447
http://dx.doi.org/10.3892/etm.2014.1574

Ejemplares similares